Product Information
DOXYCYCLINE MONO 100 MG CAP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.2349 per EA under NDC 68180065208. Its NADAC has been published 589 times since Mar 18, 2015.
Strength
100 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180065208
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOXYCYCLINEApproval Type
Generic (ANDA)
FDA Application
ANDA204234On Market Since
2/20/2015
Pharmacological Classes
Price Statistics
The NADAC for DOXYCYCLINE MONO 100 MG CAP has been published 589 times since Mar 18, 2015, and over the history we have for it it has declined 47.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2349 per EA |
|---|---|
| All-time high | $0.4788 (Jul 15, 2015) |
| All-time low | $0.1624 (Nov 20, 2024) |
| 52-week high | $0.2470 |
| 52-week low | $0.2302 |
| Median price | $0.2647 |
| Average price | $0.2990 |
| Largest weekly change | -35.2% (Nov 20, 2024) |
| Weeks tracked | 589 |
| Tracking since | Mar 18, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DOXYCYCLINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DOXYCYCLINE MONO 100 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DOXYCYCLINE MONO 100 MG CAP, manufactured by Lupin Pharmaceuticals Inc., is $0.2349 per EA (NDC 68180065208), effective Jun 24, 2026.
How has the price of DOXYCYCLINE MONO 100 MG CAP changed over time?
Over the history we have for it, the NADAC for DOXYCYCLINE MONO 100 MG CAP has declined 47.9%. It has been tracked across 589 weekly CMS publications since Mar 18, 2015.
What are the highest and lowest recorded NADAC prices for DOXYCYCLINE MONO 100 MG CAP?
Since Mar 18, 2015, the NADAC for DOXYCYCLINE MONO 100 MG CAP has ranged from a low of $0.1624 (Nov 20, 2024) to a high of $0.4788 (Jul 15, 2015), with a median of $0.2647 per EA.
Are there cheaper alternatives to DOXYCYCLINE MONO 100 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOXYCYCLINE MONO 100 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures DOXYCYCLINE MONO 100 MG CAP?
DOXYCYCLINE MONO 100 MG CAP (NDC 68180065208) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification